Double or nothing on cancer immunotherapy

Nat Biotechnol. 2013 Jan;31(1):33-4. doi: 10.1038/nbt.2471.

Abstract

Engineered T cells expressing two receptors distinguish malignant cells from healthy cells even in the absence of a tumor-specific antigen.

Publication types

  • Comment

MeSH terms

  • Antigens / immunology*
  • Combinatorial Chemistry Techniques*
  • Humans
  • Neoplasms / immunology*
  • Signal Transduction*
  • T-Lymphocytes / immunology*

Substances

  • Antigens